ClearPoint Neuro Income from Continuous Operations 2010-2024 | CLPT
ClearPoint Neuro income from continuous operations from 2010 to 2024. Income from continuous operations can be defined as a company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change
| ClearPoint Neuro Annual Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024 | $-19 |
| 2023 | $-22 |
| 2022 | $-16 |
| 2021 | $-14 |
| 2020 | $-7 |
| 2019 | $-6 |
| 2018 | $-6 |
| 2017 | $-7 |
| 2016 | $-8 |
| 2015 | $-8 |
| 2014 | $-5 |
| 2013 | $-7 |
| 2012 | $-6 |
| 2011 | $-8 |
| 2010 | $-9 |
| 2009 | $-7 |
| ClearPoint Neuro Quarterly Income from Continuous Operations (Millions of US $) |
|
|---|---|
| 2024-12-31 | $-5 |
| 2024-09-30 | $-5 |
| 2024-06-30 | $-4 |
| 2024-03-31 | $-4 |
| 2023-12-31 | $-5 |
| 2023-09-30 | $-5 |
| 2023-06-30 | $-7 |
| 2023-03-31 | $-6 |
| 2022-12-31 | $-4 |
| 2022-09-30 | $-4 |
| 2022-06-30 | $-4 |
| 2022-03-31 | $-4 |
| 2021-12-31 | $-4 |
| 2021-09-30 | $-4 |
| 2021-06-30 | $-4 |
| 2021-03-31 | $-3 |
| 2020-12-31 | $-2 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-2 |
| 2020-03-31 | $-2 |
| 2019-12-31 | $-2 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-2 |
| 2019-03-31 | $-1 |
| 2018-12-31 | $-1 |
| 2018-09-30 | $-1 |
| 2018-06-30 | $-2 |
| 2018-03-31 | $-2 |
| 2017-12-31 | $-2 |
| 2017-09-30 | $-1 |
| 2017-06-30 | $-2 |
| 2017-03-31 | $-2 |
| 2016-12-31 | $-2 |
| 2016-09-30 | $-3 |
| 2016-06-30 | $-2 |
| 2016-03-31 | $-2 |
| 2015-12-31 | $-1 |
| 2015-09-30 | $0 |
| 2015-06-30 | $-3 |
| 2015-03-31 | $-4 |
| 2014-12-31 | $-2 |
| 2014-09-30 | $-4 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $3 |
| 2013-12-31 | $-2 |
| 2013-09-30 | $-3 |
| 2013-06-30 | $-1 |
| 2013-03-31 | $-1 |
| 2012-12-31 | $1 |
| 2012-09-30 | $-3 |
| 2012-06-30 | $-1 |
| 2012-03-31 | $-3 |
| 2011-12-31 | $-2 |
| 2011-09-30 | $-2 |
| 2011-06-30 | $-2 |
| 2011-03-31 | $-2 |
| 2010-12-31 | |
| 2009-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.404B | $0.031B |
| ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California. | |||